News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,416 Results
Type
Article (8233)
Company Profile (141)
Press Release (479309)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (167037)
Career Advice (304)
Deals (25777)
Drug Delivery (8)
Drug Development (53398)
Employer Resources (14)
FDA (9808)
Job Trends (8595)
News (239034)
Policy (17980)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (497)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33300)
ALS (108)
Alzheimer's disease (985)
Antibody-drug conjugate (ADC) (296)
Approvals (10466)
Artificial intelligence (334)
ASCO (160)
Autoimmune disease (220)
Automation (29)
Bankruptcy (263)
Belgium (1)
Best Places to Work (6982)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (18)
Biotechnology (89)
Bispecific (1)
Bladder cancer (139)
Brain cancer (31)
Breast cancer (524)
Cancer (3825)
Cardiovascular disease (226)
Career advice (245)
Career pathing (1)
CAR-T (179)
CDC (1)
CDMO (16)
Celiac Disease (1)
Cell therapy (488)
Cervical cancer (37)
Clinical research (48480)
Collaboration (1287)
Commercialization (3)
Compensation (1536)
Complete response letters (35)
COVID-19 (772)
CRISPR (64)
C-suite (808)
Cystic fibrosis (87)
Data (5885)
Denatured (4)
Depression (106)
Dermatology (67)
Diabetes (354)
Diagnostics (4223)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (159)
Drug pricing (8)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73798)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88321)
Executive appointments (714)
FDA (12558)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (949)
Gene editing (126)
Generative AI (11)
Gene therapy (334)
GLP-1 (295)
Government (953)
Grass and pollen (2)
Guidances (281)
Healthcare (9395)
Hematology (95)
HIV (55)
Huntington's disease (23)
IgA nephropathy (68)
Immunology and inflammation (106)
Immuno-oncology (62)
Indications (168)
Infectious disease (964)
Inflammatory bowel disease (129)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (262)
Interviews (41)
IPO (12405)
IRA (3)
Job creations (1971)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (60)
Legal (5199)
Licensing (18)
Liver cancer (45)
Longevity (19)
Lung cancer (554)
Lymphoma (261)
Machine learning (29)
Management (3)
Manufacturing (570)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8681)
Medtech (8840)
Mergers & acquisitions (14432)
Metabolic disorders (726)
mRNA (63)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (228)
Neuropsychiatric disorders (40)
Neuroscience (1874)
NextGen: Class of 2026 (3153)
Non-profit (847)
Obesity (231)
Opinion (11)
Ovarian cancer (164)
Pain (177)
Pancreatic cancer (208)
Parkinson's disease (207)
Partnered (12)
Patents (498)
Patient recruitment (535)
Patient selection (2)
Peanut (32)
People (41418)
Peptides (2)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15672)
Phase 2 (21655)
Phase 3 (14609)
Pipeline (7732)
Policy (19)
Postmarket research (1582)
Preclinical (6616)
Press Release (35)
Prostate cancer (194)
Psychedelics (7)
Radiopharmaceuticals (200)
Rare diseases (591)
Real estate (3024)
Recruiting (6)
Regenerative medicine (2)
Regulatory (15055)
Reports (23)
Research institute (600)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (104)
Series A (163)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2033)
Stomach cancer (4)
Supply chain (52)
Vaccines (335)
Venture capital (17)
Weight loss (75)
Women's health (89)
Date
Today (28)
Last 7 days (271)
Last 30 days (1359)
Last 365 days (19099)
2026 (13701)
2025 (19288)
2024 (23071)
2023 (26632)
2022 (34703)
2021 (37326)
2020 (33589)
2019 (23318)
2018 (17541)
2017 (18859)
2016 (18019)
2015 (24337)
2014 (21747)
2013 (18183)
2012 (20245)
2011 (20489)
2010 (20388)
Location
Africa (231)
Alabama (78)
Alaska (2)
Arizona (311)
Arkansas (11)
Asia (18293)
Australia (2153)
California (12364)
Canada (3241)
China (550)
Colorado (496)
Connecticut (428)
Delaware (216)
Europe (25240)
Florida (1860)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (728)
India (52)
Indiana (324)
Iowa (16)
Japan (426)
Kansas (106)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1233)
Massachusetts (8112)
Michigan (314)
Minnesota (572)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (122)
New Hampshire (60)
New Jersey (2704)
New Mexico (12)
New York (2899)
North Carolina (1320)
North Dakota (4)
Northern California (6219)
Ohio (295)
Oklahoma (14)
Oregon (16)
Pennsylvania (2313)
Puerto Rico (21)
Rhode Island (30)
South America (407)
South Carolina (78)
South Dakota (1)
Southern California (5147)
Tennessee (125)
Texas (2006)
United States (40105)
Utah (372)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (956)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
487,416 Results for "anticancer inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial
September 8, 2026
·
24 min read
Press Releases
Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
July 13, 2026
·
11 min read
Press Releases
BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs
April 22, 2026
·
7 min read
Press Releases
Press Release: Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector
June 8, 2026
·
12 min read
Press Releases
InxMed Announces Publication in The Lancet Respiratory Medicine Featuring Promising Anticancer Activity of Ifebemtinib in combination with Garsorasib in First-Line non-small cell lung cancer (NSCLC) Harboring KRAS G12C Mutation
July 9, 2026
·
5 min read
Press Releases
MAIA Biotechnology’s Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market
February 24, 2026
·
5 min read
Press Releases
MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy
April 8, 2026
·
6 min read
Press Releases
PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101
February 6, 2026
·
2 min read
Press Releases
Totus Medicines to Present Updated Phase 1 Clinical Data for TOS-358 at ESMO Targeted Anticancer Therapies Congress 2026
February 12, 2026
·
2 min read
Press Releases
Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026
March 16, 2026
·
9 min read
1 of 48,742
Next
